Vaccine

Graphic of a one dollar bill with nuts and bolts scattered across it
Biotech

Sanofi inks $1.15B buyout to boost RSV pipeline

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing a phase 1 vaccine candidate to expand its RSV pipeline beyond mRNA.
Nick Paul Taylor Jul 22, 2025 4:20am
Robert F Kennedy Jr conducts a news conference to discuss the Centers for Disease Control and Preventions latest Autism a
Favicon Fierce Healthcare

RFK Jr. defends proposed HHS budget as Dems slam cuts

Jun 24, 2025 6:00pm
pass the torch deal sell buy acquisition

GSK offloads shigella vaccine to Bharat ahead of phase 3

Jun 12, 2025 9:18am
Messenger RNA

Arcturus doubles down on mRNA, axes several early-stage assets

May 13, 2025 1:32pm
Space shuttle takes off on background of blue sky

Manufacturer Emergent invests in next-gen vax biotech

Mar 12, 2025 10:22am
packing boxes moving layoffs failure shut down

GSK to move vaccine R&D group from Maryland to Massachusetts

Feb 12, 2025 11:27am